Literature DB >> 30280383

Porphyromonas gingivalis triggers NLRP3-mediated inflammasome activation in macrophages in a bacterial gingipains-independent manner.

Tokuju Okano1, Hiroshi Ashida1, Shiho Suzuki1, Mikio Shoji2, Koji Nakayama2, Toshihiko Suzuki1.   

Abstract

Porphyromonas gingivalis is a Gram-negative anaerobic bacterium that has been considered to be one of the bacteria associated with progression of human periodontitis. Subgingival biofilms formed by bacteria, including P. gingivalis, induce chronic inflammation, and activation of inflammasome in the gingival tissue. However, the mechanisms of P. gingivalis-triggering inflammasome activation and the role of bacteria-host interactions are controversial. In this study, we investigated the potential of P. gingivalis for triggering inflammasome activation in human cells and mouse models. We demonstrated that secreted or released factors from bacteria are involved in triggering NLR family, pyrin-domain containing 3 protein (NLRP3) inflammasome in a gingipain-independent manner. Our data indicated that released active caspase-1 and mature IL-1β are eliminated by proteolytic activity of secreted gingipains. These results elucidate the molecular bases for the mechanisms underlying P. gingivalis-triggered inflammasome activation.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Caspase-1; NLRP3 inflammasome; NOD-like receptor; Periodontitis; Porphyromonas gingivalis

Mesh:

Substances:

Year:  2018        PMID: 30280383     DOI: 10.1002/eji.201847658

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Danger signals in oral cavity-related diseases.

Authors:  Jason G Kay; Jill M Kramer; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

Review 2.  Relationship of NLRP3 inflammasome with periodontal, endodontic and related systemic diseases.

Authors:  Revan Birke Koca-Ünsal; Ahmet Özer Şehirli; Serkan Sayıner; Umut Aksoy
Journal:  Mol Biol Rep       Date:  2022-09-15       Impact factor: 2.742

Review 3.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

Review 4.  AIM2 Inflammasome's First Decade of Discovery: Focus on Oral Diseases.

Authors:  Lufei Wang; Lu Sun; Kevin M Byrd; Ching-Chang Ko; Zhenxing Zhao; Jie Fang
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

5.  Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome.

Authors:  Maomao Zhang; Yang Zheng; Yong Sun; Shuang Li; Liangqi Chen; Xiangyuan Jin; Xinyu Hou; Xianglan Liu; Qi Chen; Jing Li; Mingyang Liu; Xianghui Zheng; Yongxiang Zhang; Jian Wu; Bo Yu
Journal:  Theranostics       Date:  2019-05-24       Impact factor: 11.556

6.  Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats.

Authors:  Yi Zhang; Deshu Zhuang; Yi Zhang; Huiying Lu; Haijiao Zhang; Tingting Li; Liangjia Bi
Journal:  Drug Des Devel Ther       Date:  2020-12-15       Impact factor: 4.162

Review 7.  Pyroptosis-Mediated Periodontal Disease.

Authors:  Mariane Beatriz Sordi; Ricardo de Souza Magini; Layla Panahipour; Reinhard Gruber
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 8.  Infective Endocarditis in High-Income Countries.

Authors:  Francesco Nappi; Giorgia Martuscelli; Francesca Bellomo; Sanjeet Singh Avtaar Singh; Marc R Moon
Journal:  Metabolites       Date:  2022-07-25

Review 9.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 10.  Nrf2 in the Field of Dentistry with Special Attention to NLRP3.

Authors:  Lisa Schieffer; Claudia Manzl; Christoph Schatz; Johannes Haybaeck; Adriano Crismani
Journal:  Antioxidants (Basel)       Date:  2022-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.